We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Specialized Stent that Expands as Child Grows to Result in Fewer Heart Surgeries for Babies

By HospiMedica International staff writers
Posted on 20 Sep 2024
Print article
Image: The new device means fewer heart surgeries for babies (Photo courtesy of Cedars-Sinai)
Image: The new device means fewer heart surgeries for babies (Photo courtesy of Cedars-Sinai)

Approximately 40,000 babies are born each year in the United States with a heart defect, according to the U.S. Centers for Disease Control and Prevention. Many of these infants have narrowing in either the aorta, which carries blood from the heart to the rest of the body, or the pulmonary artery, which transports blood from the heart to the lungs. While the first stent was approved by the FDA in 1994, it was designed for adults. Until now, the only solution for babies with narrowed blood vessels has been to resize adult stents to fit their small vessels, requiring multiple replacements as the child grows. However, a new device specifically designed for infants with narrowed blood vessels is now available.

Researchers at Cedars-Sinai (Los Angeles, CA, USA), in collaboration with Renata Medical (Newport Beach, CA, USA), have developed and tested the Minima Stent System, a stent designed to grow with a child. Featuring a unique cell design, the stent can expand as the child grows, eliminating the need for open-heart surgery. Instead, the expansion is performed during a two-hour catheterization procedure, with children typically able to go home the day after the procedure. The stent, made from a metal mesh, is designed to keep blood vessels open in newborns, infants, and children with narrowing in the aorta or pulmonary artery. Its ability to expand as the child grows is intended to reduce the need for additional surgeries as larger stents are needed over time.

The U.S. Food and Drug Administration has recently approved the Minima Stent System for use in newborns, infants, and children with narrowing in the aorta or pulmonary artery. Cedars-Sinai is one of the few hospitals in the U.S. where interventional cardiologists are trained to deploy the stent and offer specialized care to children who need it. Cedars-Sinai was also one of four medical centers that participated in an early feasibility study, which helped secure FDA approval for the stent. Results of the study, published in the journal Clinical Science, demonstrated that the stent was successfully implanted and effectively opened narrowed blood vessels.

“The stents we have had up to this point have had a fixed maximum diameter, meaning that baby is going to need to get it replaced, typically through open-heart surgery,” said Evan Zahn, MD, director of the Pediatric Congenital Heart Program at Guerin Children’s and in the Department of Cardiology in the Smidt Heart Institute, and chief medical officer of Renata Medical, who helped develop the new stent. “This approval represents a monumental shift in the way we care for babies with congenital heart disease. It is a joy to know how many patients and families will be positively impacted now that the stent is more widely available.”

Related Links:
Cedars-Sinai
Renata Medical

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Plasma Thawing System
QuickThaw DH8
New
60 SMS Sterilization Wrap
Steri-Wrap Unite

Print article
Radcal

Channels

Surgical Techniques

view channel
Image: Researchers conducted an electric surgical procedure on a bile duct obstruction experimentally with a robotic convoy (Photo courtesy of DKFZ)

Miniature Robots Transport Instruments for Endoscopic Microsurgery Through Body

The potential applications for miniature robots in medicine are vast, ranging from targeted drug delivery to diagnostic tasks and performing surgical procedures. Researchers have already developed and... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.